Press release
Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size 2022 | Qiagen NV, GE Healthcare, Agilent Technologies, F Hoffman La Roche, Foundation Medicine
Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market research report delivers a systematic and comprehensive market research study, along with the facts and figures associated with any subject in the field of marketing. This report has a lot of features to offer about the Medical Devices industry such as the general market conditions, trends, inclinations, key players, opportunities, and geographical analysis. These and such other parameters help to take the business towards escalation and success. Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market report has been framed with the most excellent and superior tools for collecting, recording, estimating, and analyzing market data.Get a FREE Sample Copy of this Report with Graphs and Charts at: https://www.reportsnreports.com/contacts/requestsample.aspx?name=5810559
Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market By Company:
- Qiagen NV
- GE Healthcare
- Agilent Technologies
- F Hoffman La Roche
- Foundation Medicine
- Thermo Fisher Scientific Inc.
- Leica Biosystems Nussloch GmBH
- Pfizer
Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Segment by Type:
- PCR
- In-situ Hybridization
- Immunohistochemistry
- Sequencing
- Others
Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Segment by Application:
- Oncology
- Neurological Disorders
- Cardiovascular Disease
- Immunological Disorders
- Others
Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market By Region:
- North America
- - U.S.
- - Canada
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- Asia-Pacific
- - China
- - Japan
- - South Korea
- - India
- - Australia
- - Taiwan
- - Indonesia
- - Thailand
- - Malaysia
- - Philippines
- - Vietnam
- Latin America
- - Mexico
- - Brazil
- - Argentina
- Middle East & Africa
- - Turkey
- - Saudi Arabia
- - U.A.E
Purchase This Report: https://www.reportsnreports.com/purchase.aspx?name=5810559
Table of Contents
1 Study Coverage
1.1 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022) & (US$ Million) Introduction
1.2 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Outlook 2017 VS 2022 VS 2028
1.2.1 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size for the Year 2017-2028
1.2.2 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size for the Year 2017-2028
1.3 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Dynamics
1.4.1 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Industry Trends
1.4.2 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Drivers
1.4.3 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Challenges
1.4.4 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) by Type
2.1 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Segment by Type
2.1.1 PCR
2.1.2 In-situ Hybridization
2.1.3 Immunohistochemistry
2.1.4 Sequencing
2.1.5 Others
2.2 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017, 2022 & 2028)
2.3 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2028)
2.4 United States Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017, 2022 & 2028)
2.5 United States Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Type (2017-2028)
3 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) by Application
3.1 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Segment by Application
3.1.1 Oncology
3.1.2 Neurological Disorders
3.1.3 Cardiovascular Disease
3.1.4 Immunological Disorders
3.1.5 Others
3.2 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017, 2022 & 2028)
3.3 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2028)
3.4 United States Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017, 2022 & 2028)
3.5 United States Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Application (2017-2028)
4 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Competitor Landscape by Company
4.1 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Company
4.1.1 Top Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Companies Ranked by Revenue (2021)
4.1.2 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue by Player (2017-2022)
4.2 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Concentration Ratio (CR)
4.2.1 Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) in 2021
4.2.3 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Headquarters, Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022) & (US$ Million) Type
4.3.1 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Headquarters and Area Served
4.3.2 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Companies Revenue in Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Company
4.5.1 Top Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Players in United States, Ranked by Revenue (2021)
4.5.2 United States Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Revenue by Players (2020, 2021 & 2022)
5 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Region
5.1 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Region (2017-2028)
5.2.1 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Region: 2017-2022
5.2.2 Global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth 2017-2028
6.1.2 North America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth 2017-2028
6.3.2 Europe Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth 2017-2028
6.4.2 Latin America Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
Ask Report Queries: https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=5810559
Contact Us:
Corporate Headquarters
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India
+ 1 888 391 5441
sales@reportsandreports.com
About Us:
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) Market Size 2022 | Qiagen NV, GE Healthcare, Agilent Technologies, F Hoffman La Roche, Foundation Medicine here
News-ID: 2653676 • Views: …
More Releases from ReportsnReports
DeviceCon Series 2024 - UK Edition | MarketsandMarkets
Future Forward: Redefining Healthcare with Cutting-Edge Devices
Welcome to DeviceCon Series 2024 - Where Innovation Meets Impact!
Join us on March 21-22 at Millennium Gloucester Hotel, 4-18 Harrington Gardens, London SW7 4LH for a groundbreaking convergence of knowledge, ideas, and technology. MarketsandMarkets proudly presents the DeviceCon Series, an extraordinary blend of four conferences that promise to redefine the landscape of innovation in medical and diagnostic devices.
Register Now @ https://events.marketsandmarkets.com/devicecon-series-uk-edition-2024/register
MarketsandMarkets presents…
5th Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Confer …
London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH.
This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the…
Infection Control, Sterilization & Decontamination Conference |21st - 22nd March …
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21-22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays.
Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/
This conference aims to bring together all the stakeholders to discuss the obstacles in achieving…
Breast Augmentation Market Key Players, Demands, Cost, Size, Procedure, Shape, S …
The global Breast Augmentation Market in terms of revenue was estimated to be worth $900 million in 2020 and is poised to reach $1,692 million by 2025, growing at a CAGR of 13.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying…
More Releases for Pharmacogenomics
Pharmacogenomics - Top Companies Regional and Data Analysis
Pharmacogenomics is a branch of science, which studies the role of gene over the activity of a drugs and hence helps the refreshers in predicting the response of novel as well as previously available therapies.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00007564/?utm_source=OpenPR&utm_medium=10129
Major Companies operating in the Pharmacogenomics Market are:
• F. Hoffmann-la Roche Ltd
• Abbott
• Oxford Nanopore Technologies
• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• QIAGEN
• Agilent Technologies, Inc.
• Myriad Genetics, Inc.
• Admera Health
Contact Us:
If you have any queries about…
Pharmacogenomics Market worth $5.8 billion by 2028
North America region is witnessing increasing investments and research activities in the field of drug discovery and development. The need for advanced therapies due to rising rate of cancer has contributed to growth of the pharmacogenomics market.
Pharmacogenomics Market [https://www.marketsandmarkets.com/Market-Reports/pharmacogenomics-market-142682251.html?utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $3.5 billion in 2023 and is poised to reach $5.8 billion by 2028, growing at a CAGR of 10.6% from 2023 to…
Genetic Medicine: Unveiling the Power of Pharmacogenomics
Based on technology, the pharmacogenomics market is segmented into PCR, sequencing, microarray, gel electrophoresis, mass spectrometry, and others. The market for the PCR segment is subsegmented into real time PCR, standard PCR, and digital PCR. The PCR segment dominated the pharmacogenomics market in 2021 and is expected to register the highest CAGR during the forecast period.
Download Sample PDF Details at: https://www.theinsightpartners.com/sample/TIPRE00007564?utm_source=OpenPR&utm_medium=10776
The pharmacogenomics market is segmented on the basis of…
Complete PDF Guide On Pharmacogenomics [PDF]
According to our latest study on "Pharmacogenoics Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Technology, Application, and End User," the market is projected to reach US$ 14,107.80 million by 2028 from US$ 7,087.81 million in 2021; it is expected to grow at a CAGR of 10.3% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their…
Global Pharmacogenomics Market Size & Trends
According to a new market research report published by Global Market Estimates, the global pharmacogenomics market is projected to grow at a CAGR of 9.6% from 2023 to 2028.
The growth of the global pharmacogenomics market is driven by advancements in genomics and DNA sequencing technologies, the rising demand for personalized medicine, regulatory support from agencies like the FDA, cost-effectiveness through reduced adverse reactions, and a growing aging population with complex…
Global Pharmacogenomics Services Market Insights | 2022-2032
The Pharmacogenomics Services Market refers to the services provided by companies and laboratories that offer personalized medicine based on a patient's genetic makeup. Pharmacogenomics is the study of how an individual's genes affect their response to certain drugs, and the pharmacogenomics services market focuses on utilizing this knowledge to optimize drug therapy.
These services typically involve genetic testing to identify specific genetic variations that may impact a patient's response to certain…
